|
 |
|

04-21-2011, 08:17 PM
|
|
|
BG12 will be the oral MS drug of choice. Gilenya will fail
Biogen owns MS. BG12 will get priority review and be available soon
|

04-21-2011, 08:49 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Biogen owns MS. BG12 will get priority review and be available soon
|
The Serono rep said the same thing. Wow Biogen owns MS how old are you 10?
|

04-22-2011, 06:59 AM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Hum. Put them on something as safe as bg 12 or put them on Gilenya. There's a hard answer! Once again, you leave and this is what happens. For the loyal who stayed put, bg is their reward. And unlike novartis BIIB is taking real care of their employees. Yesterday I made 70,000 after giving uncle sam 37,000. I'm sure big pharma novartis will do the same for it's employees. The stock will go to 100 in the next 75 years! But don't worry in 3-5 years after physicians determine the long term effects of your drug they might feel comfortable using. So in 1200 days from now let me know how it's going for you. In those 1200 days Biogen will have put you right out of the race. Remember you win some and you lose some.
|

04-22-2011, 08:39 AM
|
|
cafepharmhand
|
|
Join Date: May 2010
Posts: 32
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Biogen owns MS. BG12 will get priority review and be available soon
|
Good thing for Biogen because Tysabri PML rate is rising fast.
Let's just hope there's no little hidden problems that are discovered "after" it has been rushed to market.
|

04-22-2011, 08:55 AM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Has anyone considered the unknown of how Gilenya SIGNIFICANTLY lowers the periph lymphocyte count in the body after dosing especially at steady state. That will cause serious illness and many deaths one would think. If I were prescribing this drug, I would be careful and wait it out to find out what results would be. SCARY---I AM JUST SAYING>
|

04-22-2011, 12:11 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Patient1
Good thing for Biogen because Tysabri PML rate is rising fast.
Let's just hope there's no little hidden problems that are discovered "after" it has been rushed to market.
|
Been on the market in Germany for over 10 years. No issues whatsoever. Fty is toast
|

04-22-2011, 12:13 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Patient1
Good thing for Biogen because Tysabri PML rate is rising fast.
Let's just hope there's no little hidden problems that are discovered "after" it has been rushed to market.
|
Actually the rate is not increasing one bit more than 6 months ago. The number of cases increases because the number of patients rise. Tysabri is going nowhere, so get used to it.
|

04-22-2011, 12:35 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Actually the rate is not increasing one bit more than 6 months ago. The number of cases increases because the number of patients rise. Tysabri is going nowhere, so get used to it.
|
Wow - you cannot do math. Patient rise is not so great, but the rate of PML cases is increasing. Nine more cases this month, seven last month, ten the month before that. There was a steady average of five cases per month prior. What you are seeing is a number of patients in the 2-3 year range emerging and that rate is close to 1 in 500.
Not many patients are new to Tysabri and quite a few are dropping the drug.
Read before you speak.
|

04-22-2011, 12:39 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Hum. Put them on something as safe as bg 12 or put them on Gilenya. There's a hard answer! Once again, you leave and this is what happens. For the loyal who stayed put, bg is their reward. And unlike novartis BIIB is taking real care of their employees. Yesterday I made 70,000 after giving uncle sam 37,000. I'm sure big pharma novartis will do the same for it's employees. The stock will go to 100 in the next 75 years! But don't worry in 3-5 years after physicians determine the long term effects of your drug they might feel comfortable using. So in 1200 days from now let me know how it's going for you. In those 1200 days Biogen will have put you right out of the race. Remember you win some and you lose some.
|
Who are you taking to most of us did not come from Biogen. Your bragging about 70,000 how small is your dick.
|

04-22-2011, 02:06 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Hum. Put them on something as safe as bg 12 or put them on Gilenya. There's a hard answer! Once again, you leave and this is what happens. For the loyal who stayed put, bg is their reward. And unlike novartis BIIB is taking real care of their employees. Yesterday I made 70,000 after giving uncle sam 37,000. I'm sure big pharma novartis will do the same for it's employees. The stock will go to 100 in the next 75 years! But don't worry in 3-5 years after physicians determine the long term effects of your drug they might feel comfortable using. So in 1200 days from now let me know how it's going for you. In those 1200 days Biogen will have put you right out of the race. Remember you win some and you lose some.
|
Money bags your not running a hedge fund your a sales rep. Where you spending all that money on yacht or a million dollar home let us know.
|

04-23-2011, 11:42 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Money bags your not running a hedge fund your a sales rep. Where you spending all that money on yacht or a million dollar home let us know.
|
"you're"
|

04-24-2011, 09:53 AM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
"you're"
|
You're fighting a losing battle on this one - no comprehension of the difference - but you'll get all kinds of vitriolic spew in the meantime.
|

04-24-2011, 12:07 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
"you're"
|
Look he just make 70k and a spelling expert. Did you pick out your new Mercedes with all that cash?
|

04-24-2011, 12:27 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
It's 70 more than any of us are making.
|

04-24-2011, 02:42 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
It's 70 more than any of us are making.
|
I made a great bonus selling Gilenya. Should make over 60k this year.
|

04-24-2011, 04:49 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
I made a great bonus selling Gilenya. Should make over 60k this year.
|
You're probably the only one. Ask how many will make under target bonus in a launch year.
|

04-24-2011, 07:10 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
I made a great bonus selling Gilenya. Should make over 60k this year.
|
I call BULLSHIT. I have a top 10 territory. I'm not making ANYTHING CLOSE TO NET 60,000
|

04-24-2011, 08:42 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
I call BULLSHIT. I have a top 10 territory. I'm not making ANYTHING CLOSE TO NET 60,000
|
Here since launch & I second that. BS for sure
|

04-25-2011, 07:02 AM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
I call BULLSHIT. I have a top 10 territory. I'm not making ANYTHING CLOSE TO NET 60,000
|
Take a look at the numbers you want my W2. I said I am on pace about 30k when Q2 gets paid out in June.
|

04-25-2011, 03:57 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Take a look at the numbers you want my W2. I said I am on pace about 30k when Q2 gets paid out in June.
|
Ya, ok and I'm looking at Niagra Falls in the middle of the Arizona desert.
|

04-25-2011, 05:26 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Ya, ok and I'm looking at Niagra Falls in the middle of the Arizona desert.
|
MORON look at the list Chicago,Atlanta you don't think they made 30 in half a year. You must really be dumb learn to add.
|

04-25-2011, 08:57 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
MORON look at the list Chicago,Atlanta you don't think they made 30 in half a year. You must really be dumb learn to add.
|
Impossible. Not 30
|

04-25-2011, 09:23 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Heard more people have left.
|

04-26-2011, 07:49 AM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
Heard more people have left.
|
How many more will leave or give up. Why is there no solution to the morale issue?
|

04-26-2011, 01:35 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
Quote:
Originally Posted by Anonymous
How many more will leave or give up. Why is there no solution to the morale issue?
|
Are you a degenerate? You work for NOVARTIS. This is big pharma hell. Why do you think this massive culture shift is going to suddenly occur? Who do you think is going to lead the charge? This is not biotech remember that. It has and always will be big pharma. If you don't like it here, leave cause it will NEVER EVER change. In fact, it will soon get much worse. New sanctions will be coming sooner than later.
|

04-26-2011, 02:35 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
To the originator of the thread: Aren't you putting the cart before the horse? How many drugs actually make it through the FDA and are marketed. If you've been around as long as I have, you know the answer is few. Besides, Tysabri is not dead yet. My wife's doctor wanted to put her on the drug. He tested for antibodies to the JCV virus and unfortunately she tested positive and could not receive the drug. It is extremely efficacious and has been shown to improve cognitive function, one of the conditions which my wife suffers. She's a full-time biotech rep., so you know how important these skills are to the job.
As you know, the best salespersons can create a need by overcoming objections and emphasizing the positives that the product offers. That's why these jobs pay so handsomely. Don't believe me? Try searching for a position outside the market with only pharma experience.
BTW, my wife starts on Gilenya next month. All MS medications carry side effects and risks, it's risk vs. potential benefit bestowed upon patient.
|

04-26-2011, 02:39 PM
|
|
|
Re: BG12 will be the oral MS drug of choice. Gilenya will fail
All the Biotech people that came shut up. They gave you a ton of money to read a detail aid what's the problem. You also received between 50-70k in a retention bonus yet you still complain. Go back if it's so bad nobody is forcing you to stay.
|
| Thread Tools |
|
|
| Display Modes |
Rate This Thread |
Linear Mode
|
|
Posting Rules
|
You may post new threads
You may post replies
You may not post attachments
You may not edit your posts
HTML code is Off
|
|
|
|
|